Alzheimer's & Cognition
Commentary
Boosting Alzheimer’s trial participation via Medicare Advantage ‘memory fitness programs’
Dr. Richard J. Caselli comments on a new initiative from the Global Alzheimer’s Platform (GAP) Foundation.
From the Journals
Total plasma tau correlates with dementia onset, Alzheimer’s disease
News from the FDA/CDC
FDA issues warnings to companies selling illegal Alzheimer’s treatments
The FDA targeted more than 58 products.
From the Journals
Novel plasma biomarkers may predict preclinical Alzheimer’s disease
The approach will need to be validated and translated “to a simpler automated platform suitable for wider utility.”
Feature
Phase 3 studies of antiamyloid Alzheimer’s drug crenezumab stopped
The molecule will continue to be tested in a study of familial Alzheimer’s in Colombia.
News
Frailty may affect the expression of dementia
People with higher degrees of frailty may be more likely to have more Alzheimer’s disease pathology and clinical dementia.
News
As deep sleep decreases, Alzheimer’s pathology – particularly tau – increases
EEG studies and brain imaging concur: Disrupted sleep patterns are associated with tau and amyloid in Alzheimer’s-affected regions and...
Latest News
Treating OSA with positive airway pressure decreased amyloid levels in CSF
The finding hints that improving obstructive sleep apnea in mid-life could reduce the later risk of Alzheimer’s disease.
Conference Coverage
Researchers exploring ways to mitigate aging’s impact on diabetes
LOS ANGELES – Potential preventative measures include caloric restriction, exercise, and taking metformin.
From the Journals
Nuedexta mainly prescribed for dementia, Parkinson’s
Only 15.2% of patients had multiple sclerosis or amyotrophic lateral sclerosis, the diagnoses of patients in the studies leading to the approval...
From the Journals
Cerebral small vessel disease progression linked to MCI in hypertensive patients